Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plectin plays a role in the migration and volume regulation of astrocytes: a potential biomarker of glioblastoma.
Žugec M, Furlani B, Castañon MJ, Rituper B, Fischer I, Broggi G, Caltabiano R, Barbagallo GMV, Di Rosa M, Tibullo D, Parenti R, Vicario N, Simčič S, Pozo Devoto VM, Stokin GB, Wiche G, Jorgačevski J, Zorec R, Potokar M. Žugec M, et al. Among authors: tibullo d. J Biomed Sci. 2024 Jan 23;31(1):14. doi: 10.1186/s12929-024-01002-z. J Biomed Sci. 2024. PMID: 38263015 Free PMC article.
The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms.
Galimberti S, Palumbo GA, Caracciolo F, Benedetti E, Pelosini M, Brizzi S, Ciabatti E, Fazzi R, Stelitano C, Quintana G, Conte E, Tibullo D, Di Raimondo F, Petrini M. Galimberti S, et al. Among authors: tibullo d. J Chemother. 2007 Jun;19(3):315-21. doi: 10.1179/joc.2007.19.3.315. J Chemother. 2007. PMID: 17594928 Clinical Trial.
Effects of imatinib mesylate in osteoblastogenesis.
Tibullo D, Giallongo C, La Cava P, Berretta S, Stagno F, Chiarenza A, Conticello C, Palumbo GA, Di Raimondo F. Tibullo D, et al. Exp Hematol. 2009 Apr;37(4):461-8. doi: 10.1016/j.exphem.2008.12.008. Exp Hematol. 2009. PMID: 19302920 Free article.
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias.
Stagno F, Vigneri P, Del Fabro V, Stella S, Restuccia N, Giallongo C, Massimino M, Berretta S, Pennisi MS, Tibullo D, Tirrò E, Buscarino C, Messina A, Di Raimondo F. Stagno F, et al. Among authors: tibullo d. Acta Oncol. 2010;49(1):109-10. doi: 10.3109/02841860903302913. Acta Oncol. 2010. PMID: 19842797 No abstract available.
Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation.
Barbagallo I, Vanella A, Peterson SJ, Kim DH, Tibullo D, Giallongo C, Vanella L, Parrinello N, Palumbo GA, Di Raimondo F, Abraham NG, Asprinio D. Barbagallo I, et al. Among authors: tibullo d. J Bone Miner Metab. 2010 May;28(3):276-88. doi: 10.1007/s00774-009-0134-y. Epub 2009 Nov 19. J Bone Miner Metab. 2010. PMID: 19924377 Free PMC article.
Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
Canestraro M, Galimberti S, Savli H, Palumbo GA, Tibullo D, Nagy B, Guerrini F, Piaggi S, Cine N, Metelli MR, Petrini M. Canestraro M, et al. Among authors: tibullo d. Cancer Genet Cytogenet. 2010 Jun;199(2):110-20. doi: 10.1016/j.cancergencyto.2010.02.010. Cancer Genet Cytogenet. 2010. PMID: 20471514
152 results